See every side of every news story

Published 4 days ago • loading... • Updated 4 days ago

New England Journal of Medicine Publishes Phase III ALLEGORY Data Showing Roche’s Gazyva/Gazyvaro Significantly Reduces Disease Activity in the Most Common Form of Lupus

Summary by The Manila Times

Over three quarters of people on Gazyva/Gazyvaro plus standard therapy achieved at least a four-point improvement in SRI-4, a measure that assesses disease severity and...

2 Articles

2 Articles

The Manila Times

New England Journal of Medicine publishes phase III ALLEGORY data showing Roche’s Gazyva/Gazyvaro significantly reduces disease activity in the most common form of lupus

Over three quarters of people on Gazyva/Gazyvaro plus standard therapy achieved at least a four-point improvement in SRI-4, a measure that assesses disease severity and...

4 days ago·Manila, Philippines (the)

Read Full Article

The Huntsville Item

New England Journal of Medicine Publishes Phase III ALLEGORY Data Showing Genentech’s Gazyva Significantly Reduces Disease Activity in the Most Common Form of Lupus

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 6, 2026-

4 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources2

Leaning Left1Leaning Right1Center0Last Updated3 days agoBias Distribution

50% Left, 50% Right

Bias Distribution

50% of the sources lean Left, 50% of the sources lean Right

50% Right

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Huntsville Item broke the news in 4 days ago on Friday, March 6, 2026.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics